Elevai Labs, Inc. (ELAB)

Market Cap	35.70M
Revenue (ttm)	1.03M
Net Income (ttm)	-3.51M
Shares Out	17.33M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	349,520
Open	2.13
Previous Close	2.13
Day's Range	1.54 - 2.45
52-Week Range	1.54 - 4.24
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 22, 2023

About ELAB

Elevai Labs is a physician-dispensed skincare company with a focus on modernizing aesthetic skincare. We conduct research and development to advance innovative and science-driven topical skincare that complements the medical aesthetics industry. Upon our founding in 2020, we initiated our research and development phase for our current product formulations. Since 2022, we have principally employed a business-to-business model in which we produce and commercialize a new generation of topical skincare products that contain our proprietary stem cel...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• IPO Date: Nov 21, 2023
• Employees: 16
• Stock Exchange: NASDAQ
• Ticker Symbol: ELAB